FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37375111000001101: Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
312071000001111 Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
312081000001113 Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Is a Buprenorphine 52.5micrograms/hour patches 4 patch true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has AMP Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has specific active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start